Update of the Genetic Variability of Monkeypox Virus Clade IIb Lineage B.1

• Published in: Microorganisms (Basel) Vol. 12; no. 9; p. 1874
• Main Authors: Scarpa, Fabio, Azzena, Ilenia, Ciccozzi, Alessandra, Branda, Francesco, Locci, Chiara, Perra, Maria, Pascale, Noemi, Romano, Chiara, Ceccarelli, Giancarlo, Terrazzano, Giuseppe, Fiori, Pier Luigi, Ciccozzi, Massimo, Casu, Marco, Sanna, Daria
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 11-09-2024; MDPI
• Subjects: Bayesian analysis; clade IIb; Comparative analysis; Epidemics; Evolution; Fatalities; Genetic analysis; Genetic diversity; Genetic variability; genome-based surveillance; Genomes; lineage B.1; Low level; Monkeypox; Outbreaks; phylodynamic; Population genetics; Population growth; Population number; Public health; Smallpox; Software; Vaccines; Vigilance; Viral diseases; Viruses; zoonotic disease; United Kingdom > UK; molecular epidemiology; genetics; genome-based surveillance; phylodynamic; lineage B.1; monkeypox; phylogeny; clade IIb; zoonotic disease
• ISSN: 2076-2607; 2076-2607
• DOI: 10.3390/microorganisms12091874

From 1 January 2022 to 31 May 2024, the World Health Organization (WHO) reported 97,745 laboratory-confirmed Mpox cases, including 203 deaths, across 116 countries. Despite a 2.3% decrease in new cases in May 2024 compared to April 2024, significant regional variations persist. The African Region reported the highest proportion of new cases, while other regions experienced mixed trends. Phylogenomic analyses of the Mpox virus Clade IIb lineage B.1 reveal stable genetic variability with minimal diversification. The Bayesian Skyline Plot indicates a generally stable viral population size with a modest peak in late 2023, followed by a decline. In general, the data indicate that the MPXV outbreak is primarily localized within a few consistent geographic clusters. The virus's evolution is relatively slow, as indicated by its stable genetic variability, and Clade IIb lineage B.1 does not currently show signs of rapid genetic changes or population growth. The current low level of genetic diversity should not lead to complacency. Ongoing genomic surveillance is essential for effective outbreak management and understanding. This monitoring is crucial for identifying any shifts in the virus's behavior or transmission, allowing for prompt public health responses and adjustments. In addition, continued vigilance is necessary to detect any new variants that might influence the outbreak's trajectory.